(-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis

AIM: To investigate the effect of (-)-epigallocatechin-3-gallate (EGCG) on growth of gastric cancer and its possible mechanism. METHODS: Heterotopic tumors were induced by subcutaneously injection of SGC-7901 cells in nude mice. Tumor growth was measured by calipers in two dimensions. Tumor angiogen...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Zhu, Bao-He, Zhan, Wen-Hua, Li, Zheng-Rong, Wang, Zhao, He, Yu-Long, Peng, Jun-Sheng, Cai, Shi-Rong, Ma, Jin-Ping, Zhang, Chang-Hua
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Co., Limited 2007
Témata:
Gastric Cancer
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4146988/
https://ncbi.nlm.nih.gov/pubmed/17451194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v13.i8.1162
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky